Better healthcare starts here: uOttawa making the largest investment in its history to fuel health research

Advanced Medical Research Centre
Group of person during the groudbreaking event on May 9, 2024
Left to right: MPP Karen McCrimmon, MP David McGuinty, MP Mona Fortier, Mayor Mark Sutcliffe, Dr. Julie St-Pierre, Dean Bernard Jasmin, Chancellor Claudette Commanda, VP Sylvain Charbonneau, TOH President and CEO Cameron Love, President Jacques Frémont
Members of the Ottawa health-care community joined researchers, educators, community leaders and investors May 9 to break ground on the Advanced Medical Research Centre (AMRC), the University of Ottawa’s new initiative to grow the medical biotechnology sector in the Ottawa region.

Scheduled to open in 2026, the ARMC is uOttawa’s largest capital investment in its history. It will bridge the gap between the discovery and commercialization of health-care treatments, providing 350,000 square feet of ultra-modern laboratory and research space.

Jacques Frémont

“Building quality health care for tomorrow depends on how we, as a society, invest in health research today.”

Jacques Frémont

— President and vice-chancellor at uOttawa

“Building quality health care for tomorrow depends on how we, as a society, invest in health research today,” says uOttawa President Jacques Frémont. For years, researchers, innovators and health-care leaders have noted how a shortage of up-to-date research and wet-lab facilities has limited this region’s potential to be a leader in health-care innovation and biotech commercialization. This has impeded, not only health-related research and development, but our ability to attract and retain top global talent in health-care innovation.”

Adjacent to the Faculty of Medicine, and in close proximity to the Ottawa Hospital General Campus and CHEO, the AMRC will house laboratories, technology platforms and other essential infrastructure to support the region’s rapidly expanding research initiatives. One key feature will be the Ottawa Health Innovation Hub, where researchers will team up with clinicians and investors to incubate and scale up startups to accelerate the commercialization of novel treatments. 

Dr. Bernard Jasmin

“As a result of what will soon take place at the AMRC, many people in Ottawa, in Canada, and across the world will be far better off.”

Dr. Bernard Jasmin

— Dean of the Faculty of medicine at uOttawa

“As a result of what will soon take place at the AMRC, many people in Ottawa, in Canada, and across the world will be far better off,” says Dr. Bernard Jasmin, dean of medicine at uOttawa. “And our guiding star will always be improving care outcomes for patients.”

“(The AMRC) will allow us to accelerate the pace of our discoveries and train more scientists for the future,” says Dr. Julie St-Pierre, professor at the Faculty of Medicine and associate vice-president, research support and infrastructure, at uOttawa. “It will permit basic discoveries to move quickly through the research and innovation pipeline so that we can maximize the impact of our work for the community.”

Julie St-Pierre

“(The AMRC) will permit basic discoveries to move quickly through the research and innovation pipeline so that we can maximize the impact of our work for the community.”

Dr. Julie St-Pierre

— Prof., Faculty of Medicine; associate vice-president, research support and infrastructure uOttawa

The National Capital Region is increasingly being recognized as a hub of health research and innovation. On May 6, Jean-Yves Duclos, minister of public services and procurement, announced that the University of Ottawa and McMaster University would share an investment from the Government of Canada of more than $115 million to jointly lead the new Canadian Pandemic Preparedness Hub, which will be part of the AMRC.

The AMRC promises to be a game changer for biotechnology in the National Capital Region, as the University of Ottawa and its partners chart a path to a brighter, healthier future. Better healthcare starts here.